Project Grant HT94252510956
Award Date 8/15/25
Completion Date 8/14/28
Dollars Obligated $113K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- This Project Grant award, totaling $2,685,519.00, was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant supports advanced biomedical research to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and explore methods to eradicate them. This 4-year research project, running from July 1, 2025 to June 30, 2029, aims to...
- Cedars-Sinai Medical Center will receive $501,000 through a two-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support the medical center's research project "CD44 Enhances Efficacy of the Chimeric Antigen Receptor T-Cell Therapy Against Prostate Cancer." Through this funding, Cedars-Sinai researchers will investigate using CD44 to improve the effectiveness of CAR T-cell therapy in treating...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...
- The Defense Health Agency awarded a $997,343 Project Grant to Cedars-Sinai Medical Center on September 1, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis, with a performance period running through August 31, 2028. As a leading research institution, Cedars-Sinai Medical Center specializes in translating scientific discoveries into innovative healthcare solutions...
- The Defense Health Agency awarded a $1,252,500 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to research the structure, function, and inhibition of the protein OneC2, which is a driver of prostate cancer. The grant period runs from September 30, 2025 to September 29, 2029 and will support advanced biomedical research at Cedars-Sinai Medical Center's facilities in West Hollywood, California to investigate this critical...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $974,043.00 to Cedars-Sinai Medical Center to conduct research on "Early Cardiac Biomarkers of Inflammation and Remodeling in DMD". The research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative medical solutions to address critical health challenges relevant to the...
- This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
- This Project Grant award of $1,252,479.00 from the Defense Health Agency supports Cedars-Sinai Medical Center's biomedical research to re-engineer the intratumoral myeloid-macrophage compartment and enhance the response to radiation and immunotherapy in triple-negative breast cancer. The award falls under the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful research....
- The Defense Health Agency awarded a $997,146.00 Project Grant to Cedars-Sinai Medical Center to investigate lesion-specific mechanisms driving retrograde transsynaptic degeneration of the visual axis in multiple sclerosis. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for Service Members and the public. The project will be conducted from September 30, 2023 to September 29, 2026 at...
- This federal Project Grant award, valued at $876,686.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center located in West Hollywood, California. The grant is funding research to "UNRAVEL GENOMIC REARRANGEMENTS IN EGF-MUTANT NSCLC MECHANISMS UNDERLYING RESISTANCE TO TYROSINE KINASE INHIBITORS" over a period of 3 years, from May 15, 2025 to May 14, 2028. As a leading research institution,...